Abstract
Key points This study by Cortese et al. has shown low rates of clinical outcomes especially target lesion revascularization (9%) in patients treated with Sirolimus coated balloon in large vessels. This is a nonrandomized single‐arm registry and hence significant impact on clinical practice is unlikely to be huge. Head‐to‐head randomized control trials comparing clinical outcomes between drug coated balloon versus drug eluting stents in large vessels is the way forward. Such studies are in the enrollment phase, and we eagerly look forward to the results from these studies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
